5-[3,5-Bis(trifluoromethyl)phenyl]tetrazole, 97%, 5g

4,7-Dichloroquinazoline, 95.0%, 5g

Methyl 5-bromopyridine-3-carboxylate, 99.00%, 25g

3-Bromo-4-(trifluoromethyl)benzaldehyde, 95.0%, 5g

4-Bromo-2-(1,1-difluoroethyl)-1-fluorobenzene, 25g

(4-Fluoro-2-(methoxycarbonyl)phenyl)boronic acid, 95.0%, 25g

2-AMINO-2-(4-CHLORO-3-FLUOROPHENYL)ETHAN-1-OL, 95.0%, 1g

1-((3-Bromo-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine, 95.0%, 1g

2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-4H-chromen-4-one hydrate, 95.0%, 5g

4-Hydroxy-4-(trifluoromethyl)cyclohexanecarboxylic acid, 95.0%, 250mg

GC capillary column ROTI®Cap-5 MS, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

5-METHOXYQUINOLINE-3-CARBOXYLIC ACID, 95.0%, 100mg

2,4-Difluoro-3-methoxybenzonitrile, 95.0%, 1g